Mark Campbell is CEO of Civia Health and co-founder of EmVenio Research, where he led the expansion of community-based trial sites to improve access for underrepresented populations. He previously led global service delivery at Synexus (PPD AES) and began his career at Johnson & Johnson and Amgen.
